November 13, 2014
2 min read
Save

Intraluminal shunt occlusion controls IOP, minimizes hypotony

Intraluminal occlusion of a glaucoma shunt enabled controlled IOP reduction and low rates of hypotony and other complications, according to a study.

Perspective from Douglas J. Rhee, MD

The prospective study included 116 eyes of 112 patients who underwent Baerveldt tube (Abbott Medical Optics) implantation. The most common diagnoses were open-angle glaucoma, angle closure and pseudoexfoliation.

The main outcome measure was transient or persistent hypotony, defined as IOP of 5 mm Hg or lower, or hypertony, defined as IOP exceeding 21 mm Hg. Patients were followed for 1 year.

Mean preoperative IOP was 26.9 mm Hg with a mean of three glaucoma medications.

During the first year, 30 eyes (26%) underwent laser suture lysis and 93 eyes (80%) underwent stent removal.

Transient hypotony occurred in one case, transient hypertony in 10 cases and persistent hypertony in three cases; no cases of persistent hypotony were reported.

IOP was 5 mm Hg or lower in nine eyes at one or more time points. Eight eyes (7%) developed hypotony-related complications.

Mean IOP at 1 year was 12.8 mm Hg with a mean of 1.1 glaucoma medications.

Postoperative complications occurred in 11 eyes (9%).

Qualified success with or without medications was achieved in 94% of eyes and complete success was achieved in 32% of eyes at 12 months.

Disclosure: The authors have no relevant financial disclosures.